PIASCLEDINE belongs to the SYSADOA group of slow-acting drugs (for the treatment of osteoarthritis symptoms), characterized by a significantly delayed effect.

Therefore, at the beginning of use of PIASCLEDINE, it will be necessary to reconsider the use of tablets in combination with NSAIDs and / or analgesics - the dose will most likely need to be reduced due to the increased effect of PIASCLEDINE.

PIASCLEDINE is used as a delayed-action treatment for the symptoms of hip and knee osteoarthritis and as adjunctive drugs for the treatment of periodontal disease (inflammation of the tooth root and surrounding tissue). If after 2 to 3 months you do not feel better or feel worse, you should consult your doctor.